Askin Lutfu, Tanriverdi Okan, Tibilli Hakan, Turkmen Serdar
Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey.
Interv Med Appl Sci. 2019 Oct 7;11(3):168-171. doi: 10.1556/1646.11.2019.20. eCollection 2020 Sep.
Serum C-reactive protein (CRP)/albumin ratio (CAR) is demonstrated as a more precise marker in determining the prognosis of critical diseases than albumin and CRP levels, separately. Recently, inflammatory biomarkers are increasingly used for both screening and prognosis of coronary artery disease (CAD). As an ischemia-dependent risk index, CAR is an independent marker of in-hospital and long-term all-cause mortality in ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. The results indicate that CAR is a more effective prognostic marker than either CRP or albumin.
血清C反应蛋白（CRP）/白蛋白比值（CAR）已被证明是一种比单独的白蛋白和CRP水平更精确的标志物，用于确定危重病的预后。最近，炎症生物标志物越来越多地用于冠状动脉疾病（CAD）的筛查和预后评估。作为一种缺血依赖性风险指数，CAR是接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死（STEMI）患者院内和长期全因死亡率的独立标志物。结果表明，CAR是一种比CRP或白蛋白更有效的预后标志物。
